Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

A metabolomic approach identifies differences in maternal serum in third trimester pregnancies that end in poor perinatal outcome.

Heazell AE, Bernatavicius G, Warrander L, Brown MC, Dunn WB.

Reprod Sci. 2012 Aug;19(8):863-75. doi: 10.1177/1933719112438446. Epub 2012 Apr 24.

PMID:
22534329
2.

First trimester maternal serum pregnancy-specific beta-1-glycoprotein (SP1) as a marker of adverse pregnancy outcome.

Pihl K, Larsen T, Laursen I, Krebs L, Christiansen M.

Prenat Diagn. 2009 Dec;29(13):1256-61. doi: 10.1002/pd.2408.

PMID:
19911417
3.

First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.

Cowans NJ, Spencer K, Meiri H.

Prenat Diagn. 2008 Feb;28(2):121-5. doi: 10.1002/pd.1921.

PMID:
18186153
4.

Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.

Cusick W, Rodis JF, Vintzileos AM, Albini SM, McMahon M, Campbell WA.

J Reprod Med. 1996 May;41(5):327-32.

PMID:
8725757
5.

Second-trimester fetal growth and the risk of poor obstetric and neonatal outcomes.

Fox NS, Huang M, Chasen ST.

Ultrasound Obstet Gynecol. 2008 Jul;32(1):61-5. doi: 10.1002/uog.5314.

6.

Maternal weight, height and risk of poor pregnancy outcome in Ahmedabad, India.

Mavalankar DV, Trivedi CC, Gray RH.

Indian Pediatr. 1994 Oct;31(10):1205-12.

PMID:
7875780
7.

Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.

Canini S, Prefumo F, Pastorino D, Crocetti L, Afflitto CG, Venturini PL, De Biasio P.

Fertil Steril. 2008 Jan;89(1):174-8. Epub 2007 May 16.

PMID:
17509577
8.

Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome.

Cetković A, Miljic D, Ljubić A, Patterson M, Ghatei M, Stamenković J, Nikolic-Djurovic M, Pekic S, Doknic M, Glišić A, Bloom S, Popovic V.

Endocr Res. 2012;37(2):78-88. doi: 10.3109/07435800.2011.639319.

PMID:
22489921
9.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
10.

Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.

Simpson JL, Palomaki GE, Mercer B, Haddow JE, Andersen R, Sibai B, Elias S.

Am J Obstet Gynecol. 1995 Dec;173(6):1742-8.

PMID:
8610755
11.

Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies.

Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, Graf K, Vetter K, Abou-Dakn M, Herrera E.

Diabet Med. 2011 Sep;28(9):1053-9. doi: 10.1111/j.1464-5491.2011.03346.x.

PMID:
21658120
12.

Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery.

Morssink LP, Kornman LH, Hallahan TW, Kloosterman MD, Beekhuis JR, de Wolf BT, Mantingh A.

Prenat Diagn. 1998 Feb;18(2):147-52.

PMID:
9516016
13.

Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome.

Idris I, Srinivasan R, Simm A, Page RC.

Clin Endocrinol (Oxf). 2005 Nov;63(5):560-5.

PMID:
16268809
14.

C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the Generation R Study.

Ernst GD, de Jonge LL, Hofman A, Lindemans J, Russcher H, Steegers EA, Jaddoe VW.

Am J Obstet Gynecol. 2011 Aug;205(2):132.e1-12. doi: 10.1016/j.ajog.2011.03.049. Epub 2011 Apr 8.

15.

Outcomes of pregnancies complicated by systemic lupus erythematosus (SLE).

Phadungkiatwattana P, Sirivatanapa P, Tongsong T.

J Med Assoc Thai. 2007 Oct;90(10):1981-5.

PMID:
18041412
16.

Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.

Hawkins TL, Roberts JM, Mangos GJ, Davis GK, Roberts LM, Brown MA.

BJOG. 2012 Mar;119(4):484-92. doi: 10.1111/j.1471-0528.2011.03232.x. Epub 2012 Jan 18.

17.

Maternal serum caffeine metabolites and small-for-gestational age birth.

Klebanoff MA, Levine RJ, Clemens JD, Wilkins DG.

Am J Epidemiol. 2002 Jan 1;155(1):32-7.

PMID:
11772782
18.

Effect on neonatal outcomes in gestational hypertension in twin compared with singleton pregnancies.

Luo ZC, Simonet F, An N, Bao FY, Audibert F, Fraser WD.

Obstet Gynecol. 2006 Nov;108(5):1138-44.

PMID:
17077235
20.

[Maternal and perinatal outcomes in pregnant women with leukemia].

Nomura RM, Igai AM, Faciroli NC, Aguiar IN, Zugaib M.

Rev Bras Ginecol Obstet. 2011 Aug;33(8):174-81. Portuguese.

Supplemental Content

Support Center